A case series of sarcoidosis with pulmonary involvement: Various clinical and radiographic manifestations

Journal of the Medical Association of Thailand

Volumn 96, Issue 8, 2013, Pages 888-897

  Disayabutr, Supparerk ^a   Pattanaprichakul, Penvadee ^a   Ruangchira Urai, Ruchira ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Etanercept; Granulomatous disease; Non necrotizing granuloma; Pulmonary involvement; Sarcoidosis

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; ETANERCEPT; METHOTREXATE; PREDNISOLONE;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CD4 CD8 RATIO; CERVICAL LYMPHADENOPATHY; CHEST TIGHTNESS; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAM; FATIGUE; FEMALE; FOLLOW UP; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERKERATOSIS; KERATOSIS; LUNG BIOPSY; LUNG FUNCTION TEST; LUNG LAVAGE; LUNG SARCOIDOSIS; LYMPHADENOPATHY; MALE; PARATHYROID HORMONE BLOOD LEVEL; RETROSPECTIVE STUDY; SARCOIDOSIS; SKIN BIOPSY; SKIN DEFECT; SPIROMETRY; SPONDYLOARTHROPATHY; THORAX RADIOGRAPHY; TRANSBRONCHIAL ASPIRATION; UVEITIS;

ADULT; AGED; BRONCHOALVEOLAR LAVAGE FLUID; DISEASE PROGRESSION; FEMALE; HUMANS; LYMPHATIC DISEASES; MALE; MIDDLE AGED; PULMONARY DIFFUSING CAPACITY; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SARCOIDOSIS, PULMONARY; SPIROMETRY;

EID: 84881484330     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Reich JM, Johnson RE. Incidence of clinically identified sarcoidosis in a northwest United States population. Sarcoidosis Vasc Diffuse Lung Dis 1996; 13: 173-7.
2. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-41.
3. Lodha S, Sanchez M, Prystowsky S. Sarcoidosis of the skin: a review for the pulmonologist. Chest 2009; 136: 583-96.
4. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-65.
5. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Statement on sarcoidosis. Am J Respir Crit Care Med 1999; 160: 736-55.
6. Muangman N, Suttinont P, Chierakul N. Pulmonary sarcoidosis: classic radiographic finding. Siriraj Med J 2008; 60: 28-30.
7. Manonukul J, Wanitphakdeedecha R, Wisuthsarewong W, Thirapote P. Histopathologic aid to diagnosis of sarcoidosis: report of 8 cases. J Med Assoc Thai 2006; 89: 864-71.
8. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years' observation. Br Med J 1961; 2: 1165-72.
9. Hashimoto M, Watanabe O, Sato K, Endo K, Heianna J, Itoh I, et al. The CT findings of pulmonary sarcoidosis. Tohoku J Exp Med 1996; 179: 259-66.
10. Sharma OP. Cutaneous sarcoidosis: clinical features and management. Chest 1972; 61: 320-5.
11. Epstein WL. Cutaneous sarcoidosis. Semin Respir Crit Care Med 2002; 23: 571-7.
12. Mañá J, Marcoval J, Graells J, Salazar A, Peyri J, Pujol R. Cutaneous involvement in sarcoidosis. Relationship to systemic disease. Arch Dermatol 1997; 133: 882-8.
13. Fernandez-Faith E, McDonnell J. Cutaneous sarcoidosis: differential diagnosis. Clin Dermatol 2007; 25: 276-87.
14. Wakelin SH, James MP. Sarcoidosis: nail dystrophy without underlying bone changes. Cutis 1995; 55: 344-6.
15. Bjermer L, Thunell M, Rosenhall L, Stjernberg N. Endobronchial biopsy positive sarcoidosis: relation to bronchoalveolar lavage and course of disease. Respir Med 1991; 85: 229-34.
16. Agarwal R, Srinivasan A, Aggarwal AN, Gupta D. Efficacy and safety of convex probe EBUS-TBNA in sarcoidosis: a systematic review and meta-analysis. Respir Med 2012; 106: 883-92.
17. Gilman MJ, Wang KP. Transbronchial lung biopsy in sarcoidosis. An approach to determine the optimal number of biopsies. Am Rev Respir Dis 1980; 122: 721-4.
18. Shorr AF, Torrington KG, Hnatiuk OW. Endobronchial biopsy for sarcoidosis: a prospective study. Chest 2001; 120: 109-14.
19. Costabel U, Zaiss AW, Guzman J. Sensitivity and specificity of BAL findings in sarcoidosis. Sarcoidosis 1992; 9(Suppl 1): 211-4.
20. Welker L, Jorres RA, Costabel U, Magnussen H. Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases. Eur Respir J 2004; 24: 1000-6.
21. Marshall R, Smellie H, Baylis JH, Hoyle C, Bates DV. Pulmonary function in sarcoidosis. Thorax 1958; 13: 48-58.
22. Alhamad EH, Lynch JP III, Martinez FJ. Pulmonary function tests in interstitial lung disease: what role do they have? Clin Chest Med 2001; 22: 715-50.
23. Finkel R, Teirstein AS, Levine R, Brown LK, Miller A. Pulmonary function tests, serum angiotensin-converting enzyme levels, and clinical findings as prognostic indicators in sarcoidosis. Ann N Y Acad Sci 1986; 465: 665-71.
24. Gibson GJ, Prescott RJ, Muers MF, Middleton WG, Mitchell DN, Connolly CK, et al. British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax 1996; 51: 238-47.
25. Daien CI, Monnier A, Claudepierre P, Constantin A, Eschard JP, Houvenagel E, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford) 2009; 48: 883-6.
26. Clementine RR, Lyman J, Zakem J, Mallepalli J, Lindsey S, Quinet R. Tumor necrosis factor-alpha antagonist-induced sarcoidosis. J Clin Rheumatol 2010; 16: 274-9.
27. Burns AM, Green PJ, Pasternak S. Etanercept-induced cutaneous and pulmonary sarcoid-like granulomas resolving with adalimumab. J Cutan Pathol 2012; 39: 289-93.
28. Tong D, Manolios N, Howe G, Spencer D. New onset sarcoid-like granulomatosis developing during anti-TNF therapy: An under-recognised complication. Intern Med J 2012; 42: 89-94.
29. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000; 161: 646-64.